Lentiviral vectors are now widely considered one of the safest and most efficient tools for gene delivery and stable gene expression. Even though inducible gene expression cassettes are mandatory for many genetic engineering strategies, most current systems suffer from various issues, such as the requirement of two vectors, which decreases the overall efficiency of the transduction, leakiness and/or insufficient levels of activation of the inducible promoter, lack of selectable marker, low titers, or general issues associated with the cloning of large plasmids. In this article, we describe the design and functional characterization of a set of “all-in-one” multicistronic autoinducible lentivectors. They combine: (1) an optimized drug-inducible promoter; (2) a multicistronic strategy to express living color, selectable marker, and transactivator; and (3) acceptor sites for easy recombination cloning of genes of interest. These polyswitch lentivectors have good titers, very low basal activity, and reversible high induced activity, and can accept a growing number of genes already cloned in entry plasmids. These combined features make them a novel, powerful, and versatile tool for current and future genetic engineering approaches.
Get full access to this article
View all access options for this article.
References
1.
BardeI., Zanta-BoussifM.A., PaisantS.et al.2006. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol. Ther., 13:382–390.
2.
BernardP., KezdyK.E., Van MelderenL.et al.1993. The F plasmid CcdB protein induces efficient ATP-dependent DNA cleavage by gyrase. J. Mol. Biol., 234:534–541.
3.
CartierN., Hacein-Bey-AbinaS., BartholomaeC.C.et al.2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 326:818–823.
4.
CorishP., Tyler-SmithC.1999. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng., 12:1035–1040.
5.
CurtinJ.A., DaneA.P., SwansonA.et al.2008. Bidirectional promoter interference between two widely used internal heterologous promoters in a late-generation lentiviral construct. Gene Ther., 15:384–390.
6.
DayerA.G., JennyB., SauvainM.O.et al.2007. Expression of FGF-2 in neural progenitor cells enhances their potential for cellular brain repair in the rodent cortex. Brain, 130:2962–2976.
7.
DelortJ.P., CapecchiM.R.1996. TAXI/UAS: a molecular switch to control expression of genes in vivo. Hum. Gene Ther., 7:809–820.
8.
DonnellyM.L., HughesL.E., LukeG.et al.2001. The ‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring ‘2A-like’ sequences. J. Gen. Virol., 82:1027–1041.
9.
DouinV., BornesS., CreancierL.et al.2004. Use and comparison of different internal ribosomal entry sites (IRES) in tricistronic retroviral vectors. BMC Biotechnol., 4:16.
10.
DullT., ZuffereyR., KellyM.et al.1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol., 72:8463–8471.
11.
GasconS., Paez-GomezJ.A., Diaz-GuerraM.et al.2008. Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons. J. Neurosci. Methods, 168:104–112.
12.
GossenM., BujardH.1992. Tight control of gene expression in mammalian cells by tetracycline- responsive promoters. Proc. Natl. Acad. Sci. U.S.A., 89:5547–5551.
13.
GossenM., FreundliebS., BenderG.et al.1995. Transcriptional activation by tetracyclines in mammalian cells. Science, 268:1766–1769.
HartleyJ.L., TempleG.F., BraschM.A.2000. DNA cloning using in vitro site-specific recombination. Genome Res., 10:1788–1795.
16.
HeinzN., SchambachA., GallaM.et al.2011. Retroviral and transposon-based tet-regulated all-in-one vectors with reduced background expression and improved dynamic range. Hum. Gene Ther., 22:166–176.
17.
HiokiH., KuramotoE., KonnoM.et al.2009. High-level transgene expression in neurons by lentivirus with Tet-Off system. Neurosci. Res., 63:149–154.
18.
HolstJ., VignaliK.M., BurtonA.R., VignaliD.A.2006. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat. Methods, 3:191–197.
KnottA., GarkeK., UrlingerS.et al.2002. Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows. Biotechniques, 32:796–798800 passim.
22.
KoponenJ.K., KankkonenH., KannastoJ.et al.2003. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther., 10:459–466.
23.
KosticC., ChiodiniF., SalmonP.et al.2003. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina. Gene Ther., 10:818–821.
24.
LeuchtenbergerS., PerzA., GatzC., BartschJ.W.2001. Conditional cell ablation by stringent tetracycline-dependent regulation of barnase in mammalian cells. Nucleic Acids Res., 29:e76.
25.
MarkusicD., Oude-ElferinkR., DasA.T.et al.2005. Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter. Nucleic Acids Res., 33:e63.
26.
MullickA., XuY., WarrenR.et al.2006. The cumate gene-switch: a system for regulated expression in mammalian cells. BMC Biotechnol., 6:43.
27.
NegroniM., BucH.2001. Mechanisms of retroviral recombination. Annu. Rev. Genet., 35:275–302.
28.
NoD., YaoT.P., EvansR.M.1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A., 93:3346–3351.
29.
PelletierJ., SonenbergN.1988. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature, 334:320–325.
30.
PlutaK., LuceM.J., BaoL.et al.2005. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J. Gene Med., 7:803–817.
31.
ReiserJ., LaiZ., ZhangX.Y., BradyR.O.2000. Development of multigene and regulated lentivirus vectors. J. Virol., 74:10589–10599.
32.
Ritz-LaserB., GauthierB.R., EstreicherA.et al.2003. Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription. Diabetologia, 46:810–821.
33.
RiveraV.M., ClacksonT., NatesanS.et al.1996. A humanized system for pharmacologic control of gene expression. Nat. Med., 2:1028–1032.
34.
RobertsonB.H., GrubmanM.J., WeddellG.N.et al.1985. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J. Virol., 54:651–660.
35.
SalmonP., TronoD.2007. Production and titration of lentiviral vectors. Curr. Protoc. Hum. Genet., 54:12.10.1–12.10.24.
36.
SasakiY., SoneT., YoshidaS.et al.2004. Evidence for high specificity and efficiency of multiple recombination signals in mixed DNA cloning by the Multisite Gateway system. J. Biotechnol., 107:233–243.
37.
ShengY., LinC.C., YueJ.et al.2010. Generation and characterization of a Tet-On (rtTA-M2) transgenic rat. BMC Dev. Biol., 10:17.
38.
SuterD.M., CartierL., BettiolE.et al.2006. Rapid generation of stable transgenic embryonic stem cell lines using modular lentivectors. Stem Cells., 24:615–623.
39.
SuterD.M., MontetX., TirefortD.et al.2007. A tetracycline-inducible lentivector system based on EF1alpha promoter and native tetracycline repressor allows in vivo gene induction in implanted ES cells. J. Stem Cells, 2:63–72.
40.
SzulcJ., WiznerowiczM., SauvainM.O.et al.2006. A versatile tool for conditional gene expression and knockdown. Nat. Methods, 3:109–116.
41.
SzymczakA.L., WorkmanC.J., WangY.et al.2004. Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat. Biotechnol., 22:589–594.
42.
TianX., WangG., XuY.et al.2009. An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum. Gene Ther., 20:113–123.
43.
VieyraD.S., GoodellM.A.2007. Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells, 25:2559–2566.
44.
VignaE., AmendolaM., BenedicentiF.et al.2005. Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector. Mol. Ther., 11:763–775.
45.
VogelR., AmarL., ThiA.D.et al.2004. A single lentivirus vector mediates doxycycline-regulated expression of transgenes in the brain. Hum. Gene Ther., 15:157–165.
46.
VutskitsG.V., SalmonP., MayorL.et al.2006. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells. Breast Cancer Res. Treat., 99:143–153.
47.
WangY., O'MalleyB.W.Jr., TsaiS.Y., O'MalleyB.W.1994. A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U.S.A., 91:8180–8184.
48.
ZhouQ., BrownJ., KanarekA.et al.2008. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature, 455:627–632.
49.
ZuffereyR., DullT., MandelR.J.et al.1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol., 72:9873–9880.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
